Publications by authors named "Miguel Taron"

Claim this Profile
M
MicroRNAs as potential predictors of extreme response to tyrosine kinase inhibitors in renal cell cancer.
Carmen Garrigós, Sonia Molina-Pinelo, Ricardo Meléndez, Marta Espinosa, Antonio Lerma, Miguel Taron

Urol Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
,
, , and as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study.
David S Moura, Paloma Sanchez-Bustos, Antonio Fernandez-Serra, María Lopez-Alvarez, José L Mondaza-Hernandez, Miguel Taron

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.
Javier Martin-Broto, Silvia Stacchiotti, Antonio Lopez-Pousa, Andres Redondo, Daniel Bernabeu, Miguel Taron

Lancet Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma.
Regina Alemany, David S Moura, Andres Redondo, Javier Martinez-Trufero, Silvia Calabuig, Miguel Taron

Clin Cancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients.
David S Moura, Rafael Ramos, Antonio Fernandez-Serra, Teresa Serrano, Julia Cruz, Miguel Taron

Oncotarget· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma.
Carmen Garrigós, Marta Espinosa, Ana Salinas, Ignacio Osman, Rafael Medina, Miguel Taron

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum.
Bartomeu Massuti, Manuel Cobo, Carlos Camps, Manuel Dómine, Mariano Provencio

Lung Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology Workshop.
Isabel Bover, Christian Rolfo, Eloisa Jantus-Lewintre, Rafael Sirera, Carlos Camps, Miguel Taron

Lung Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan.
Eva Martinez-Balibrea, Jose Luis Manzano, Anna Martinez-Cardus, Teresa Moran, Beatriz Cirauqui, Miguel Taron

Oncol Rep· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
Miguel Taron, Yukito Ichinose, Rafael Rosell, Tony Mok, Bartomeu Massuti

Clin Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer.
Rafael Rosell, Miguel Taron, Agusti Barnadas, Giorgio Scagliotti, Carme Sarries

Cancer Control· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients.
Carlos Camps, Carmen Sarries, Bárbara Roig, José Javier Sanchez, Cristina Queralt

Clin Lung Cancer· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis